Showing results (3261-3270 of 3,354) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|July 18, 2023
Economic and Humanistic Burden of Osteoarthritis: An Updated Systematic Review of Large Sample StudiesXuejing Jin, Wanxian Liang, Lining Zhang, et al.
Pharmacoeconomics|July 6, 2023
A Systematic Review of Cost-Effectiveness Studies of Newer Non-Insulin Antidiabetic Drugs: Trends in Decision-Analytical Models for Modelling of Type 2 Diabetes MellitusHenrik Vitus Bering Laursen, Emmelie Ploug Jørgensen, Peter Vestergaard, et al.
Pharmacoeconomics|July 1, 2023
Cost-Effectiveness of Emerging Treatments for Atopic Dermatitis: A Systematic ReviewKatja C Heinz, Charlotte Beaudart, Damon Willems, et al.
Pharmacoeconomics|August 17, 2023
Multiplier Effects and Compensation Mechanisms for Inclusion in Health Economic Evaluation: A Systematic ReviewMarieke Krol, Nikkie Hosseinnia, Werner Brouwer, et al.
Pharmacoeconomics|June 2, 2023
A Systematic Review of the Cost-Effectiveness Analyses of Anaplastic Lymphoma Kinase (ALK) Inhibitors in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)Lara Chayab, Natalia Konstantelos, Natasha B Leighl, et al.
Pharmacoeconomics|September 14, 2023
Modelling Health State Utilities as a Transformation of Time to Death in Patients with Non-Small Cell Lung CancerAnthony J Hatswell, Mohammad A Chaudhary, Giles Monnickendam, et al.
Pharmacoeconomics|June 21, 2023
Jumping the Queue:Willingness to Pay for Faster Access to COVID-19 Vaccines in Seven European CountriesSebastian Neumann-Böhme, Iryna Sabat, Carolin Brinkmann, et al.
Pharmacoeconomics|June 20, 2023
Informal Caregiving Provision for Disabled or Elderly in the Families and Work Productivity: Evidence from 11 Waves of an Australian Population-Based CohortSyed Afroz Keramat, Rubayyat Hashmi, Bolaji Samson Aregbeshola, et al.
Pharmacoeconomics|June 15, 2023
Modeling Monthly Migraine-Day Distributions Using Longitudinal Regression Models and Linking Quality of Life to Inform Cost-Effectiveness Analysis: A Case Study of Fremanezumab in Japanese-Korean Migraine PatientsXinyu Wang, Kentaro Yamato, Yoshitsugu Kojima, et al.
Pharmacoeconomics|May 28, 2023
Cost-Effectiveness Analysis of MammaPrint® to Guide the Use of Endocrine Therapy in Patients with Early-Stage Breast CancerMarianne Luyendijk, Agnes Jager, Sanne M Buijs, et al.
Pageof 336